• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于间变性星形细胞瘤和多形性胶质母细胞瘤中70个基因座杂合性缺失的研究及其对肿瘤演变的意义。

A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.

作者信息

Wooten E C, Fults D, Duggirala R, Williams K, Kyritsis A P, Bondy M L, Levin V A, O'Connell P

机构信息

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284-7750, USA.

出版信息

Neuro Oncol. 1999 Jul;1(3):169-76. doi: 10.1093/neuonc/1.3.169.

DOI:10.1093/neuonc/1.3.169
PMID:11550311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1920743/
Abstract

Cancers that arise from astrocytes in the adult CNS present as either anaplastic astrocytomas (AAs) or as more aggressive glioblastomas multiforme (GBMs). GBMs either form de novo or progress from AAs. We proposed to examine the molecular genetic relationship between these CNS tumors by conducting a genome-wide allelic imbalance analysis that included 70 loci on examples of AA and GBM. We found significant loss of heterozygosity (LOH) at 13 discrete chromosomal loci in both AAs and GBMs. Loss was significant in both AAs and GBMs at 9 of these loci. AAs show the highest rates of LOH at chromosomes 1p, 4q, 6p, 9p, 11p, 11q, 13q, 14q, 15p, 17p, 17q, and 19q. GBMs showed the greatest losses at 1p, 6q, 8p, 9p, 10p, 10q, 11p, 13q, 17p, 17q, 18p, 18q, and 19q. GBMs also demonstrated significant amplification at the epidermal growth factor receptor locus (7p12). These data suggest that there are three classes of loci involved in glioma evolution. First are loci that are likely involved in early events in the evolution of both AAs and GBMs. The second class consists of AA-specific loci, typified by higher LOH frequency than observed in GBMs (4q, 6p, 17p, 17q, 19q). The third class consists of GBM-specific loci (6q, 8p, 10, 18q). Damage at these loci may either lead to de novo GBMs or permit existing AAs to progress to GBMs. Glioma-related LOH profiles may have prognostic implications that could lead to better diagnosis and treatment of brain cancer patients.

摘要

源自成人中枢神经系统星形胶质细胞的癌症表现为间变性星形细胞瘤(AA)或更具侵袭性的多形性胶质母细胞瘤(GBM)。GBM要么是原发性形成,要么是由AA进展而来。我们提议通过进行全基因组等位基因不平衡分析来研究这些中枢神经系统肿瘤之间的分子遗传关系,该分析涵盖了AA和GBM样本中的70个位点。我们在AA和GBM中均发现13个离散染色体位点存在显著的杂合性缺失(LOH)。在这些位点中的9个位点,AA和GBM中的缺失均很显著。AA在染色体1p、4q、6p、9p、11p、11q、13q、14q、15p、17p、17q和19q上显示出最高的LOH率。GBM在1p、6q、8p、9p、10p、10q、11p、13q、17p、17q、18p、18q和19q上显示出最大程度的缺失。GBM在表皮生长因子受体位点(7p12)也表现出显著扩增。这些数据表明,胶质瘤演变涉及三类位点。首先是可能参与AA和GBM演变早期事件的位点。第二类是AA特异性位点,其特征是LOH频率高于GBM(4q、6p、17p、17q、19q)。第三类是GBM特异性位点(6q、8p、10、18q)。这些位点的损伤可能导致原发性GBM的形成,或者使现有的AA进展为GBM。胶质瘤相关的LOH图谱可能具有预后意义,从而有助于改善脑癌患者的诊断和治疗。

相似文献

1
A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.一项关于间变性星形细胞瘤和多形性胶质母细胞瘤中70个基因座杂合性缺失的研究及其对肿瘤演变的意义。
Neuro Oncol. 1999 Jul;1(3):169-76. doi: 10.1093/neuonc/1.3.169.
2
High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours.高分辨率全基因组等位基因分型分析确定14号染色体长臂缺失是星形细胞瘤中一种常见的基因改变。
Br J Cancer. 2002 Jul 15;87(2):218-24. doi: 10.1038/sj.bjc.6600430.
3
Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.星形细胞瘤患者中1p和19q的杂合性状态及其与p53蛋白表达和表皮生长因子受体(EGFR)扩增的相关性:来自印度的新系列研究
Cancer Genet Cytogenet. 2010 Apr 15;198(2):126-34. doi: 10.1016/j.cancergencyto.2009.12.018.
4
[Progression-associated gene regions in astrocytomas: a candidate locus on chromosome 19q].[星形细胞瘤中与进展相关的基因区域:19号染色体长臂上的一个候选基因座]
Verh Dtsch Ges Pathol. 1994;78:423-6.
5
Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.与星形细胞瘤恶性进展相关的基因座:19号染色体长臂上的一个候选基因座。
Cancer Res. 1994 Mar 15;54(6):1397-401.
6
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
7
A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression.人类胶质瘤中22q13.3区域的常见缺失与星形细胞瘤进展相关。
Int J Cancer. 2000 Feb 1;85(3):336-9.
8
Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.利用放射治疗肿瘤学组试验的组织微阵列,通过荧光原位杂交分析1p、19q、9p和10q作为高级别星形细胞瘤的预后标志物。
Neuro Oncol. 2004 Apr;6(2):96-103. doi: 10.1215/s1152851703000231.
9
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.通向多形性胶质母细胞瘤的途径:65例星形细胞瘤基因改变的分子分析
J Neurosurg. 1994 Sep;81(3):427-36. doi: 10.3171/jns.1994.81.3.0427.
10
Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.在星形细胞瘤进展过程中获得胶质母细胞瘤表型与10q25 - qter区域杂合性缺失相关。
Am J Pathol. 1999 Aug;155(2):387-94. doi: 10.1016/S0002-9440(10)65135-8.

引用本文的文献

1
Potential of sonobiopsy as a novel diagnosis tool for brain cancer.超声活检作为一种新型脑癌诊断工具的潜力。
Mol Ther Oncol. 2024 Jun 24;32(3):200840. doi: 10.1016/j.omton.2024.200840. eCollection 2024 Sep 19.
2
Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.神经母细胞瘤易位激酶基因缺失频率在神经胶质瘤中较低,且在神经胶质瘤球体中存在偏倚。
Mol Cancer. 2013 Dec 11;12:160. doi: 10.1186/1476-4598-12-160.
3
Emerging biomarkers in glioblastoma.胶质母细胞瘤的新兴生物标志物。
Cancers (Basel). 2013 Aug 22;5(3):1103-19. doi: 10.3390/cancers5031103.
4
Current progress for the use of miRNAs in glioblastoma treatment.miRNAs 在胶质母细胞瘤治疗中的应用的最新进展。
Mol Neurobiol. 2013 Dec;48(3):757-68. doi: 10.1007/s12035-013-8464-0. Epub 2013 Apr 28.
5
Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme.加拿大复发性或进行性多形性胶质母细胞瘤治疗推荐。
Curr Oncol. 2011 Jun;18(3):e126-36. doi: 10.3747/co.v18i3.755.
6
Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.具有少突胶质成分的胶质母细胞瘤-不同组织学部分的共同起源和遗传亚分类。
Cell Oncol (Dordr). 2011 Jun;34(3):261-75. doi: 10.1007/s13402-011-0034-8. Epub 2011 May 3.
7
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.替莫唑胺:其在恶性星形细胞瘤中治疗效果的证据。
Core Evid. 2010 Jun 15;4:93-111. doi: 10.2147/ce.s6010.
8
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.多形性胶质母细胞瘤的肿瘤基因组学与信号通路
Clin Med Oncol. 2009 Apr 8;3:39-52. doi: 10.4137/cmo.s1008.
9
Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma.皮肤恶性黑色素瘤中异常的脂肪酸结合蛋白-7 基因表达。
J Invest Dermatol. 2010 Jan;130(1):221-9. doi: 10.1038/jid.2009.195.
10
Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study.对决策无影响的预后分子标志物:基于一项前瞻性研究的胶质瘤悖论
Br J Cancer. 2008 Jun 3;98(11):1830-8. doi: 10.1038/sj.bjc.6604378. Epub 2008 May 27.